Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans

iScience(2022)10.1016/j.isci.2022.104409Source: DataRank Database

The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans is a research paper published in iScience (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.36)OA: goldTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Mackenzie L. Cottrell ORCID,John P. Prybylski ORCID,Angela D. M. Kashuba ORCID,Ronald S. Veazey ORCID,Javier García‐Pérez ORCID

Live enrichment

PubMed:35663021 PMC:PMC9157191 OpenAlex:https://openalex.org/W4280569490

NIAID NIH HHS

Grant: P30 AI050410

NIH HHS

Grant: P51 OD011104

NIAID NIH HHS

Grant: R21 AI094515

European Commission

Grant: 242135

Combined Highly Active Anti-retroviral Microbicides

National Institutes of Health

Grant: 5R21AI094515-03

Mucosal tissue explants as surrogates for in vivo efficacy of microbicides

FWCI

0.36

Citation Percentile

0.6%

Citation Trend

2022

2023

2025

2026

goldLicense: cc-by

journalhttp://www.cell.com/article/S2589004222006800/pdf

publisherhttp://www.cell.com/article/S2589004222006800/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2589004222006800?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2589004222006800?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.isci.2022.104409

Fields of Study

HIV Research and TreatmentHIV/AIDS Research and InterventionsHerpesvirus Infections and Treatments0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MaravirocExplant cultureEx vivoIn vivoPotencyPharmacologyPharmacokineticsCCR5 receptor antagonistHuman immunodeficiency virus (HIV)MedicineBiologyANTIRETROVIRAL AGENTSIn vitroImmunologyViral loadAntiretroviral therapyInflammationBiotechnologyBiological sciencestoxicologyNatural SciencesBiological Sciences Research MethodologiesScienceQ610Articlename=SDG 3 - Good Health and Well-being616/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being